ArticleJournal of family medicine and primary care2022
Determination of safe sites of intramuscular arm injections and its relevance to the community.
Article in Journal of family medicine and primary care, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 3 citations in OpenAlex.
- Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Introduction: Intramuscular injections are usually given in the arm or the gluteal region. Needle insertions done through the intramuscular route in the arm are almost always administered at a point 1 - 2 cm above the insertion of the deltoid. However, this site is not such an ideal one as found by certain other workers. Hence, this study was done to establish a series of safe determinant points in and around the arm in the South Indian population of the state of Telangana. Materials and Methods: The five proven safe injection points were tested through needle insertions by observing sterile aseptic precautions in the arms of 370 subjects at the outpatient department of a national level medical research institute after obtaining their consent following the universal safety protocol. Results: The points I [1 to 2 cm above deltoid insertion], II [a point midway between the midpoint of arm and insertion of deltoid] and III [midpoint between anterior acromion and deltoid insertion] were found to be safe for administering intramuscular arm injections in this subset of the population. Conclusion: This explains the erratic course of the anterior branches of the axillary nerve in different geographical populations. Hence, needle insertion points for arm intramuscular injections need to be determined according to the region.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.